Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Nobutaka, Yoshida"'
Publikováno v:
Bioscience, Biotechnology, and Biochemistry. 75:148-151
We cloned the genes encoding the two distinct extracellular halotolerant proteases of Bacillus subtilis FP-133 Expro-I and Expro-II, which were classified as alkaline serine and neutral proteases respectively. Three-dimensional modeling suggested tha
Autor:
Nobutaka Yoshida, Masae Yorimitsu, Jun Noma, Akio Masumoto, Kei Hayata, Yukiko Tatsumoto, Madoka Sekino, Makoto Ishida, Reina Komatsu
Publikováno v:
Choonpa Igaku. 38:283-289
骨系統疾患は100種類以上存在するが,個々の疾患頻度は低く診断に苦慮することが多い.中には予後不良な疾患も含まれ,正確な出生前診断を要する.今回,骨系統疾患を同時期に2例経
Autor:
Jun Noma, Tomomi Okada, Masahiko Nakata, Nobutaka Yoshida, Madoka Sekino, Masahiro Sumie, Kei Hayata, Takashi Akiyama, Makoto Ishida, Reina Komatsu
Publikováno v:
Choonpa Igaku. 38:481-487
胎児胸水を伴う肺分画症の予後は不良である.胎児胸水除去及びシャント術を行うことで,胎児水腫や肺低形成が予防でき,予後の改善につながると言われている.胎児胸腔‐羊水腔シ
Publikováno v:
KOBUNSHI RONBUNSHU. 56:702-708
ポリエチレン・パウダー試料を透過型電子顕微鏡 (TEM) 観察するために, ガラス繊維布のバスケットを用いた四酸化ルテニウム染色後に薄切を行った. この方法により, 分子量分布の異なる
Autor:
Shigeki, Takekida, Keiichi, Fujiwara, Shoji, Nagao, Satoshi, Yamaguchi, Nobutaka, Yoshida, Fuminori, Kitada, Junzo, Kigawa, Naoki, Terakawa, Ryuichiro, Nishimura
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 20(9)
The efficacy and toxicity of combination chemotherapy with docetaxel + carboplatin were evaluated in patients with locally advanced or recurrent cervical cancer. A total of 71 patients with cervical cancer were enrolled into this trial, and 66 patien
Autor:
Yoshio Osawa, Nobutaka Yoshida
Publikováno v:
Biochemistry. 30:3003-3010
A simple and efficient method is described for the purification of microsomal aromatase cytochrome P-450 from human placenta. The enzyme was solubilized with Emulgen 913 and sodium cholate and subjected to chromatography on a column of Sepharose 4B c
Autor:
Jun, Noma, Nobutaka, Yoshida
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 35(6)
Standard therapy for advanced ovary cancer is T-C chemotherapy (paclitaxel, carboplatin) after initial cytoreductive surgery. Intraperitoneal (i.p.) chemotherapy has been studied for several decades to improve the survival rate in ovarian cancer. The
Autor:
Nobutaka Yoshida, Maehata K, Noriaki Sakuragi, Sachiko Suzuki, Takayuki Koshida, Masashi Nishiya, Hideaki Sawai, Eriko Aotani, Keiichi Fujiwara, Ichiro Kohno
Publikováno v:
Gynecologic oncology. 90(3)
Objective Currently, no long-term follow-up data are available on intraperitoneal (IP) carboplatin-based chemotherapy for ovarian carcinoma. In this study we evaluated retrospectively the survival and recurrence of a retrospective cohort of patients
Publikováno v:
The Journal of steroid biochemistry and molecular biology. 37(5)
Activities of aromatase cytochrome P-450 in the columnar epithelial region (CE), squamous epithelial region (SE) and connective tissue (CT) of uterine cervix, and endometrium (EM) during the menstrual cycle were determined using [4-14C] and [1 beta-3